SCHEMBL904089

SCHEMBL904089

CCc1cnc(N2C[C@H]3C[C@@H](O)C[C@H]3C2)nc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
KDM4E B2RXH2 1/20 0.36
OGA O60502 1/20 0.35
HDAC3 O15379 3/20 0.34
HDAC4 P56524 3/20 0.34
HDAC1 Q13547 3/20 0.34
HDAC7 Q8WUI4 3/20 0.34
HDAC2 Q92769 3/20 0.34
HDAC10 Q969S8 3/20 0.34
HDAC11 Q96DB2 3/20 0.34
HDAC8 Q9BY41 3/20 0.34
HDAC6 Q9UBN7 3/20 0.34
HDAC9 Q9UKV0 3/20 0.34
HDAC5 Q9UQL6 3/20 0.34
GPR119 Q8TDV5 5/20 0.34
ACACB O00763 4/20 0.34
RBP4 P02753 1/20 0.34
PDE8B O95263 1/20 0.33
PDE5A O76074 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10068057 0.90 NPC1 (0.40) NPC1RAB9AKDM4EOGAHDAC3
SCHEMBL12525218 0.86 OGA (0.38) NPC1RAB9AKDM4EOGAHDAC3
SCHEMBL904091 0.84 GPR119 (0.36) NPC1RAB9AKDM4EOGAHDAC3
SCHEMBL10067572 0.80 ACACB (0.44) NPC1RAB9AKDM4EOGAGPR119
SCHEMBL10067707 0.80 ACACB (0.44) NPC1RAB9AKDM4EOGAGPR119
SCHEMBL904079 0.79 KDM4E (0.42) NPC1RAB9AKDM4EGPR119
SCHEMBL12506042 0.77 AOC3 (0.49) OGAHDAC6GPR119ACACBPDE8B
SCHEMBL15312801 0.77 AOC3 (0.49) OGAHDAC6GPR119ACACBPDE8B
SCHEMBL357797 0.77 AOC3 (0.44) NPC1RAB9AKDM4EOGAGPR119
SCHEMBL18794986 0.76 HDAC3 (0.37) NPC1RAB9AKDM4EOGAHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012041158-A1 TRICYCLIC COMPOUND, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-04-05 WO disclosed